The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention

BACKGROUND AND OBJECTIVES: The outcome benefits of β-blockers in chronic coronary artery disease (CAD) have not been fully assessed. We evaluated the prognostic impact of β-blockers on patients with chronic CAD after percutaneous coronary intervention (PCI). METHODS: A total of 3,075 patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jiesuck, Han, Jung-Kyu, Kang, Jeehoon, Chae, In-Ho, Lee, Sung Yun, Choi, Young Jin, Rhew, Jay Young, Rha, Seung-Woon, Shin, Eun-Seok, Woo, Seong-Ill, Lee, Han Cheol, Chun, Kook-Jin, Kim, DooIl, Jeong, Jin-Ok, Bae, Jang-Whan, Yang, Han-Mo, Park, Kyung Woo, Kang, Hyun-Jae, Koo, Bon-Kwon, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257156/
https://www.ncbi.nlm.nih.gov/pubmed/35491482
http://dx.doi.org/10.4070/kcj.2021.0395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257156/
https://www.ncbi.nlm.nih.gov/pubmed/35491482
http://dx.doi.org/10.4070/kcj.2021.0395

Ejemplares similares